ÂÜÀòÂÒÂ×

Michelle Saylor is a highly experienced professional in vaccine and product development, currently serving as Sr. Director and Vaccine Development Team Lead at the Sabin Vaccine Institute. Prior roles include Senior Director at Emergent BioSolutions, where responsibilities encompassed leading Product Development Teams and overseeing program strategy and compliance for multiple projects, including those funded by BARDA and CEPI. Experience also encompasses positions such as Product Compliance Scientist at the U.S. Army Medical Materiel Development Activity and Biodefense Regulated Laboratory Scientist at the U.S. Army Medical Research Institute of Infectious Diseases. Michelle holds a Master's Degree in Microbiology and Immunology from Georgetown University, an MBA in Finance from the Robert H. Smith School of Business at the University of Maryland, and a Bachelor's Degree in Biology from Shepherd University, complemented by a Certificate in Regulatory Compliance from Hood College.